Latest Event Updates
Hadoop-as-a-Service (HaaS) Market is Expected to Reach $16.1 Billion Globally by 2020 – Allied Market Research
According to the latest report by Allied Market Research titled, “Global Hadoop-as-a-Service (HaaS/HDaaS) Market (Deployment Type, End User, Geography) – Industry Analysis, Trends, Share, Opportunities and Forecast, 2013- 2020″, the global HaaS market is expected to reach $16.1 billion by 2020, registering a CAGR of 70.8% from 2014 to 2020. In the current business scenario, HaaS market is majorly constricted to North America. Amazon Elastic Map Reduce was the most prominent service, accounting to nearly 85% of the global market revenue in 2013.
HaaS made a grand ingress in the big data analytic market in last couple of years. The advent of this novel technology is highly appreciated among the data scientists and among the SMEs. The market has doubled itself in 2013 (from 2012) and is now gaining prominence among conventional Hadoop users. Noteworthy, Hadoop-as-a-service is expected to give a tough competition to on-premises-Hadoop in the coming years. The outburst of HaaS is anticipated to overcast the growth of the on-premises Hadoop market through 2020. With an optimistic view, AMR analysts further predict that the market would witness a strong bullish run during 2020 – 2025.
Browse the full report with TOC(Table of Contents) at http://www.alliedmarketresearch.com/hadoop-as-a-service-market
“Hadoop in the Cloud” (HaaS/HDaaS) holds numerous benefits over conventional Hadoop. Low upfront cost (for both run it yourself and pure play HaaS) and non-technical interface (in case of pure play) are the crucial dynamics propelling the market. Many providers are coming up with graphic and excel based interfaces, which makes Hadoop operations easier than ever. HaaS adds flow to business operations as providers take sole responsibility of running and managing Hadoop jobs. SMEs, social media firms, SaaS providers. Gaming companies are largely contributing to HaaS revenue, and the growing demand for HaaS by these business entities is further fuelling the market.
Persisting security concerns and lack of awareness among end users are the only pullbacks for the market growth. Information technology is acting as a boon in creating HaaS awareness among target customers. Persisting security concerns are also anticipated to die down to an extent due to the adoption of private clouds and high security cloud storages. AWS has already made a move in this direction with “AWS GovCloud (U.S. region)” that complies with the U.S. International Traffic in Arms Regulations (ITAR) requirements.
The evolution of smaller pure play/managed HaaS players, despite the presence of giants such as IBM and Microsoft, has grabbed the attention as these smaller players are making strong inroads to the market. However, AWS has been a common storage platform for most of these HaaS providers. Cloudera, one of the leaders in Hadoop, offers CDH3 as a HaaS offering. Microsoft Corporation, IBM Corp., Amazon Web Services, Cloudera, Inc., Datameer, Inc., Hortonworks, MAPR Technologies, Emc Corp., Mortar Data Inc. and Altiscale are among key market participants analyzed in this report.
This report by Allied Market Research is the latest in the Hadoop market research reports series and provides answers to a number of questions as below; however, not limited to:
- How is the HaaS going to shadow on-premises-hadoop?
- What verticals are most adopters of HaaS and what will be the future scenario?
- Which deployment type is currently most profitable and what are the future prospects?
- Who is ripping the early-mover advantage? Who would be the leader in future?
- Where is the money and growth?
The new report by Allied Market Research titled, “DNA diagnostics Market (products, applications, techniques, end users and Geography) Global Size, Industry Analysis, Trends, Opportunities, Growth and Forecast, 2013 – 2020,” indicates that the global DNA diagnostics market would reach $19 billion by 2020 registering a CAGR of 9.8% from 2014 to 2020. The potential to provide accurate diagnosis and cost effectiveness over alternative diagnostic techniques are factors which supplement the growth of the DNA diagnostics market.
The latest figures suggest that approximately 8.2 million people are living with cancer and 39 million with HIV. These numbers are set to increase consistently; however, advanced automated DNA diagnostics technologies such as next generation sequencing could play a crucial role in diagnosing and curbing these diseases. “Next generation sequencing has had a significant impact on diagnostic procedures and is set to gain momentum in the foreseeable future.”, states AMR analyst Sharayu Dhabale. “Next generation sequencing not only reduces the cost of sequencing, but increases the throughput as well; it could thus help in bridging the gaps in traditional and personalized medications”, adds the analyst. This makes it a promising investment opportunity for key players. Illumina Inc’s new cost-effective genome machine HiSeq X Ten -the world’s first DNA crunching supercomputer- is leading to a significant reduction in the price of sequencing a human genome.
To View the complete report, visit the website at http://www.alliedmarketresearch.com/DNA-diagnostics-market
AMR analysis suggests that the tremendous potential of novel DNA diagnostic technologies and the probability of them being adopted in personalized medicines has not only reduced the expenditure in diagnostic procedures but has also helped in increasing the efficiency of chronic disease identification. Furthermore, the emergence of personalized medicines and the rising number of initiatives vis-à-vis product development and clinical trials from key players has laid the groundwork for DNA diagnostics technologies. Various technologies such as PCR, sequencing technology, microarray, in situ hybridization and mass spectrometry are considered in this report, with special emphasis on key market trends and their growth potential. Given its wide scope of application in almost all activities related to DNA diagnostics, the polymerase chain reaction (PCR) technology holds the largest share of DNA diagnostics market revenue.
Market analysis in terms of geography suggests that developed economies would retain their dominance in the market. This could be attributed to the early adoption of the technology due to potential reduction offered by DNA diagnostic to their high healthcare expenditure. However, developing economies, such as in Asia-Pacific, will significantly influence the DNA diagnostic market during the extended forecast period (2020-2025), largely due to potential growth in per capita healthcare expenditure and very large undiagnosed population.
Several companies operating in this region are seeking novel technologies to gain traction in the competitive market. Product launch is the key strategy adopted by companies operating in this market. These companies are developing novel products for the treatment of various diseases such as infectious diseases, cancer, prenantal diagnosis, pre-implantation diagnostics and myogenic disorder. Additionally, these companies are also adopting collaboration and acquisition to retain their respective positions and to gain traction in the market. Key companies profiled in the report are Bayer Diagnostic, Sysmex, Roche Diagnostics, Abbott laboratories, Cephide, Gene-probe Inc., Illumina, Inc., Thermo Fisher Scientific, Bio-Rad Laboratories, Johnson and Johnson, and Novartis.
According to a new report by Allied Market Research titled, “Global Graphene Market (Bulk material, Film, Product Type, Applications, Geography) – Industry Analysis, Trends, Share, Opportunities and Forecast, 2013- 2020″, the global graphene market is expected to reach $149.1 million by 2020, registering a CAGR of 44.0% from 2014 to 2020. North America is and will be the largest Graphene market through 2020. Asia Pacific is anticipated to be the fastest growing region with a CAGR of 42.9% due to high growth of electronics and automotive industries, which are among top consumers of Graphene. In terms of volume, 1.8 kilo tons of Graphene bulk and 26.7 million square cm of Graphene films will be consumed by 2020.
Browse the full report with TOC at http://www.alliedmarketresearch.com/graphene-market
Graphene has been justly conferred the title of ‘Wonder Material’ owing to its exceptional strength and thinness. Characteristics such as mechanical strength (200 times stronger than steel), electrical and optical properties, ensures that Graphene has wide application in energy, automotive, aerospace, electronics, biomedical, and such others. Latterly, product and technology development is on the rise that is evident by the fact that about 3,018 Graphene patent applications were granted by July 2011 that almost tripled to 8,413 byFebruary 2013. Moreover, the European Union has created a Flagship program for graphene, allocating about $1.3 billion to spend on the development of Graphene over the next 10 years. Such movements are instrumental in allowing commercial parity and faster growth of the Graphene market.
Majority of the companies involved in the Graphene business have employed product launch as their primary business strategy, particularly concerning monolayer & bi-layer graphene, Graphene Oxide (GO) and graphene nano platelet (GNP). Unfortunately, high-priced equipment and incapability of mass production are factors which restrain the growth of the market. Nonetheless, chemical vapor deposition (CVD) is rendering better production capabilities to counter mass production issues. Graphene counterparts such carbon nano tubes (CNT) and nanoclays are presenting stiff challenge; however, Graphene stands price competitive with CNTs and tops in performance when compared to nanoclays. As mass production increases, there is potential for 70% to 80% price drop, making Graphene far competitive to its counterparts.
Key products, such as GNP, is one of the potential segments in the overall market owing to its low cost, early adoption and application in graphene based composites. GO and monolayer & bi-layer graphene will emerge as lucrative segments in the long run due to their usage in large applications, chiefly in electronics, energy, aerospace and coatings. Few layer graphene has not yet received substantial attention, due to higher prices with low volume production. Graphene electronics and energy storage remains most popular application markets due to the early adoption by players in aforesaid industries.
Key graphene producers such as CVD Equipment Corporation, Graphene Nanochem PLC, Vorbrck Materials, XG Sciences, Haydale Limited, Graphenea, Graphene Laboratories, Bluestone Global Tech, Angstron Material, Inc. and ACS Material, LLC have adopted product development and agreement as their key developmental strategies to gain competitive edge in the graphene market.
According to a new market research report by Allied Market Research titled, Global3D Scanning Market (Type, Forms, Services, Applications, Geography) – Industry Analysis, Trends, Share, Opportunities and Forecast, 2013-2020“, the global 3D scanning market is forecast to reach $4.9 billion by 2020 registering a CAGR of 12.4% during the forecast period (2014 – 2020). The market would remain to be dominated by the North American and European region, collectively contributing to more than two third of the global revenue share. However, Asia-Pacific region would also generate significant global revenue by 2020 with rapid growth. The revenue growth is due to growing adoption within industries such as healthcare, entertainment, etc. and also due to relevant developments in China, Japan, and India.
The 3D laser scanners are gaining widespread adoption in the various industries. The comparatively easier portability and relatively low-priced laser scanners are the key factors influencing the market adoption. By recognizing the potential of this type of scanners, numerous companies are launching their scanners based on laser technology. 3D laser scanners of companies such as Faro Technologies, Direct Dimensions inc., Creaform (now Ametek Inc.), etc. are preferred in various industries such as manufacturing, pipe check solutions, civil, etc.
Get full access of the report at http://www.alliedmarketresearch.com/3D-scanning-market
The initiatives taken by the governments across world to enhance health care sector and provide superior health care facilities are driving the adoption of 3D scanners in healthcare industry. The scanners have been very efficient in scanning the human body with their short and medium range scanning capabilities. The high-quality scanners provided by numerous vendors in the market are effective in diagnosing hidden problems in the human body. The rising demand for better and sophisticated healthcare facilities and growing health conscious populace in the developing countries is further responsible for the technological adoption.
3D scanning, an integral domain of 3D technology, refers to the method used to capture a three dimensional view of an object along with information such as colour, texture, etc. 3D scanning makes it possible to record the details of an object while minimizing the overall time, cost and effort required in the process. Various industries prefer reverse engineering as 3D scanning service since few years.
AMR’s analysis confers that reverse engineering services are the most promising services, anticipating significant revenue generation through 2020. Various industrial applications such as manufacturing, automobile, defence, etc. choose reverse engineering as a service of 3D scanning due to its effective analysis and modification of industry specific products. Recently, Geomagic launched its Design X solution in the 3D scanning market, which assists in reverse engineering by effectively capturing the object details and converting it to computer readable forms. Laser Design, Inc. offers its own versions of laser scanners in the market for reverse engineering. Faro Technologies had launched its own versions of laser scanners operating in different ranges to facilitate reverse engineering. However, face/body scanning would rapidly grow over time due to applications in medical and varied security related instruments. Shorter-range operations of 3D scanners are most commonly preferred due to the finest detail capturing capabilities. Laser scanners are most commonly used type in short range scanning. Handheld short range scanners developed by Faro Technologies, Creaform (now Ametek Inc.), GOM mbH, etc. are popular in the market in applications such as entertainment, healthcare, automotive, pipe inspection, etc.
The companies profiled in the report include Faro Technologies, Ametek Inc., Quality Vision International, Direct Dimensions Inc., GOM mbH, Konica Minolta, Inc., 3D Digital Corporation, Autodesk Inc., 3D Systems, Inc., ShapeGrabber and Maptek Pty Ltd.
A new report by Allied Market Research titled, “Global biosimilars/follow-on-biologics market (types, applications and geography) – Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 – 2020″, suggests that the global biosimilars market would reach $35 billion by 2020 from the estimated $1.3 billion in 2013. Deeper penetration with clearer regulatory pathways in developed markets and higher efficacy & safety in emerging markets will back the market growth during the forecast period.
Over 10 blockbuster biologics with annual sales of $60 billion are facing patent expiries in Europe and in the U.S. during the next four years. Top pharmaceutical manufacturing brands are repositioning their strategic agendas from approvals to product launches to gain market capitalization. “Biosimilars developers have been using emerging markets with less intellectual property protection as their launch pad for established markets” say AMR analysts. “With regulatory framework maturing in established markets, it will be easier for biosimilars manufacturers to quickly enter into such markets” analysts added, citing collaboration between Mylan and Biocon to commercialize biosimilar of trastuzumab in India and the approval of first biosimilar version of monoclonal antibody drug by Hospira inEurope. Due to lower intellectual property rights protection and higher activity of regional players, the Asia Pacific region has emerged as the leader in biosimilars market.
Browse the report with TOC at http://www.alliedmarketresearch.com/biosimilars-market
Biosimilars as a cost effective alternative provides room for economical biopharmaceutical medications for chronic disorders that are rampant around the globe. The widespread chronic disorders and the need for cost effective medication is driving the biosimilars commercialization. The strategic collaborations for global expansion, especially for the high potential segments such as monoclonal antibodies (mAbs) and erythropoietin will be key to the market growth; however, the strategies are persistently threatened by traditional patent-infringements. Key product segments such as follitropins, interferons, and insulin biosimilars will emerge lucrative segments in the long run. Certain therapeutic classes such as oncology and autoimmune diseases will gain importance from the biosimilars developers as these classes will have higher room for growth due to awaited patent expiries during 2014 – 2019.
AMR analysis suggests that Erythropoietin biosimilars are the most promising products, anticipating substantial revenue generation from patented biologics. Granulocyte colony-stimulating factor biosimilars are following erythropoietin in terms of revenue generation during the forecast period. Biosimilars in oncology disorders are currently dominating the market due to high-priced patented drugs such as erythropoietin and monoclonal antibodies that are largely used in the oncology treatments. However, biosimilars for chronic and autoimmune diseases and blood disorders are the fastest growing applications and expecting a salutary growth during the analysis period.
Key biosimilars developers such as Novartis (Sandoz), Synthon Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., LG Life Sciences, Celltrion, Biocon, Hospira, Merck Serono (Merck Group), Biogen idec, Inc. and Genentech (Roche Group) have adopted approval and clinical trials as key developmental strategies to gain competitive edge in the pharmaceuticals market. These firms are also focusing on adhering to regulatory guidelines to expand in the world markets.
According to the report titled “3D Printing Market (Technologies, Materials, Applications and Geography) – Global Opportunity Analysis and Forecast-2013-2020″, the global 3D printing market will reach $8.6 billion by 2020, registering a CAGR of 20.6% from 2014 to 2020. The surge in growth is primarily due to rising demand for faster and more efficient ways to manufacture complex design objects using a wide array of materials.
The adoption of 3D printing in various applications is growing on account of higher accuracy, efficient use of material and ability to build customized products. Its competency over traditional processes, time efficiency and simultaneous use of multiple materials has been the other prominent adoption drivers. However, higher cost of personal printing, expensive software, and lack of channel partner assistance has been restraining the growth of the market. The economies of scale gained through advancement in technology and improved manufacturing process will help the market grow in future.
To view the complete report visit the website at http://www.alliedmarketresearch.com/3d-printing-market
Stereolithography, selective laser sintering, electron beam melting, fused deposition modeling, and laminated object manufacturing are some of the technologies currently being used for 3D printing. Stereolithography accumulated the largest revenue in 2013, which accounted for about 33% of the overall market. Electron beam melting is expected to be the fastest growing technology segment projecting a CAGR of 26.7% during the forecast period (2014-2020).
Polymers, metals, and ceramics among others are the key 3D printing materials included for analysis in the report. Polymer occupy major share in 3D printing materials market, generating revenue of $193.3 million in 2013. Metal and alloy is projected to be the fastest growing material segment and is projected to grow at a CAGR of 40.5% during 2014-2020.
The increasing adoption of 3D printing in various application segments such as consumer products, industrial products, aerospace, automotive, defense, healthcare, education & research, architecture and arts are facilitating the growth of 3D printing market. The key industry segments such as healthcare and aerospace, which are growing at a promising rate, have witnessed significant penetration of 3D printing technology. Consumer product industry remains the largest application segment with about 22% of the market share, while defense sector is expected to exhibit the fastest growth at a CAGR of 17.2%during the forecast period.
North America leads the 3D printing market with about 43.9% revenue share in 2013, followed closely by European region. The dominance of North American market is attributed to the growth in healthcare, consumer, aerospace and automobile industry. Asia-Pacific would be the fastest growing market, having a CAGR of 51.9% during 2014-2020, due to faster adoption of 3D printing in the developing industrial sectors.
The competitive analysis and strategies followed by key market players is also presented in the report. The companies mentioned in the report include 3D Systems, Stratasys, Arcam AB, Autodesk, ExOne, Hoganas AB, Optomec, Organovo Holdings, Ponoko and Voxeljet Ag.
According to the new report by Allied Market Research, titled “Global Cloud Services Market (Services, Type, End User and Geography) – Global Analysis, Industry Growth, Trends, Size, Share, Opportunities and Forecast, 2013-2020“, the global cloud services market is expected to grow at a CAGR of 17.6% from 2014 to 2020, reaching a market size of $555 billion in 2020. In 2014, the overall cloud services market revenue will reach $209.9 billion, led by public cloud services. The community cloud services segment is gaining momentum and is expected to garner revenue of $1 billion this year, thanks to its adoption in healthcare segment.
Cloud computing market surged during recent economic slowdown; with the fact that over 35% of the IT cost can be saved with the adoption of the technology. Since then cloud services segment has greatly emerged as companies in cash crunch required cost-effective solutions with minimum to zero investment and reduced management of IT resources. Although, the cost and functional benefits such as scaling ability and multi-tenancy still driving much of the cloud services market growth, evolution of much value-creating productive solutions has become the current growth function of the market. The cloud, from an exploratory potential option, has now grown to become the undeniable part of organizations’ overall IT portfolio. However, data security has still concerned a number of sensitive potential end users to opt for the cloud services.
Detailed report with TOC is available at http://www.alliedmarketresearch.com/cloud-services-market
Strong growth is anticipated within the varied segments of cloud services market such as infrastructure as a service (IaaS), software as a service (SaaS), platform as a service (PaaS), business process as a service (BPaaS), cloud advertisement services, and cloud management & security services. Cloud advertising services will be the largest segment followed BPaaS with about 47% and 28% market share respectively in 2013. The cloud management & security services will be the fastest growing segment at a CAGR of 28.4% during the forecast period.
On the basis of cloud type the market is categorized as public cloud, private cloud, hybrid cloud and community cloud. Public cloud hold prominent share of the market through 2020 and is expected grow at a CAGR of 16.4% during the forecast period. The reduction of the total cost of ownership on deployment of cloud services acts as the major driver for the adoption of public clouds. The market attracts numerous new entrants due to liberal government regulations. Private cloud will have fastest growth during the analysis period whereas hybrid and community cloud services will gain gradual momentum with steady adoption within specialized end use segments.
Based on end users, cloud services market can be segmented into government utilities, private organizations, healthcare, academics & education and supply chain management. Private organizations lead the end user market due to the rapidly growing IT sector, which is contributing largely to the revenue streams of the private organizations segment. The segment is expected to grow at a CAGR of 24.1% during the forecast period and it is anticipated to register revenue of $86.8 billion by 2020. Cloud services promote sector-specific services, which are customized for specific end users. One such example is the implementation of ERP in the healthcare sector.
Varied market dynamics has been observed within the geographic market segments for cloud services. North America region being the early adopter of these services holds the highest market share throughout the analysis period. The fastest growing market is the Asia Pacific which is growing with a CAGR of 23.5% during the forecast period while representing a smaller market. Economic benefits from cloud services acts as the key driving factors in developing countries of Asia Pacific.